UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 185

Sortiert nach

Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials

The Lancet (British edition), 2014-08, Vol.384 (9943), p.599-606

2014

Link zum Volltext

Verfügbarkeit prüfen

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Circulation (New York, N.Y.), 2014-10, Vol.130 (18), p.1579-1588

2014

Link zum Volltext

Verfügbarkeit prüfen

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials

The lancet. Diabetes & endocrinology, 2015-05, Vol.3 (5), p.356-366

2015

Link zum Volltext

Verfügbarkeit prüfen

Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention

Journal of the American College of Cardiology, 2021-07, Vol.78 (3), p.216-229

2021

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, Predictors, and In-Hospital Outcomes of Non-Infarct Artery Intervention During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction (from the National Cardiovascular Data Registry)

The American journal of cardiology, 2009-08, Vol.104 (4), p.507-513

2009

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c

The American journal of medicine, 2016-03, Vol.129 (3), p.340.e1-340.e8

2016

Link zum Volltext

Verfügbarkeit prüfen

Impact of Type 2 Myocardial Infarction (MI) on Hospital‐Level MI Outcomes: Implications for Quality and Public Reporting

Journal of the American Heart Association, 2018-04, Vol.7 (7), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Contemporary Trends and Outcomes of Percutaneous and Surgical Aortic Valve Replacement in Patients With Cancer

Journal of the American Heart Association, 2020-01, Vol.9 (2), p.e014248-e014248

2020

Link zum Volltext

Verfügbarkeit prüfen

State Mandated Public Reporting and Outcomes of Percutaneous Coronary Intervention in the United States

The American journal of cardiology, 2015-06, Vol.115 (11), p.1494-1501

2015

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

Circulation (New York, N.Y.), 2017-08, Vol.136 (9), p.849-870

2017

Link zum Volltext

Verfügbarkeit prüfen

Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction

The American heart journal, 2016-02, Vol.172, p.9-18

2016

Link zum Volltext

Verfügbarkeit prüfen

Meta‐analysis of transfemoral TAVR versus surgical aortic valve replacement

Catheterization and cardiovascular interventions, 2018-03, Vol.91 (4), p.806-812

2018

Link zum Volltext

Verfügbarkeit prüfen

Differences in Inpatient Outcomes After Surgical Aortic Valve Replacement at Transcatheter Aortic Valve Replacement (TAVR) and Non-TAVR Centers

Journal of the American Heart Association, 2019-11, Vol.8 (22), p.e013794-e013794

2019

Link zum Volltext

Verfügbarkeit prüfen

Response to Letter Regarding Article, “Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial”

Circulation (New York, N.Y.), 2015-08, Vol.132 (6), p.e121-e122

2015

Link zum Volltext

Verfügbarkeit prüfen

Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial

The American heart journal, 2015-05, Vol.169 (5), p.622-630.e6

2015

Link zum Volltext

Verfügbarkeit prüfen

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)

Circulation (New York, N.Y.), 2017-07, Vol.136 (3), p.249-259

2017

Link zum Volltext

Verfügbarkeit prüfen

In-Hospital Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Octogenarians

Journal of the American Heart Association, 2019-01, Vol.8 (2), p.e011206-e011206

2019

Link zum Volltext

Verfügbarkeit prüfen

Patient and Hospital Characteristics Associated With Inappropriate Percutaneous Coronary Interventions

Journal of the American College of Cardiology, 2013-12, Vol.62 (24), p.2274-2281

2013

Link zum Volltext

Verfügbarkeit prüfen

Collaborative quality improvement vs public reporting for percutaneous coronary intervention: A comparison of percutaneous coronary intervention in New York vs Michigan

The American heart journal, 2015-12, Vol.170 (6), p.1227-1233

2015

Link zum Volltext

Verfügbarkeit prüfen

Do Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure?

JACC. Heart failure, 2014-12, Vol.2 (6), p.583-585

2014

Link zum Volltext

Verfügbarkeit prüfen

Another Step Forward in Our Ability to Predict Percutaneous Coronary Intervention Outcomes

The American journal of cardiology, 2023-11, Vol.206, p.332-333

2023

Link zum Volltext

Verfügbarkeit prüfen

Are All Clinical Trial Sites Created Equal?

Journal of the American College of Cardiology, 2013-02, Vol.61 (5), p.580-581

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Circulation (New York, N.Y.), 2015-09, Vol.132 (10), p.923-931

2015

Link zum Volltext

Verfügbarkeit prüfen

Temporal Trends and Predictors in the Use of Aldosterone Antagonists Post-Acute Myocardial Infarction

Journal of the American College of Cardiology, 2013-01, Vol.61 (1), p.35-40

2013

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure lowering in the prevention of type 2 diabetes

The Lancet (British edition), 2021-11, Vol.398 (10313), p.1778-1779

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 185

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(168)
Mit Volltextzugriff
(170)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(105)
Life Sciences & Biomedicine
(103)
Humans
(75)
Cardiac & Cardiovascular Systems
(70)
Cardiovascular System & Cardiology
(70)
Male
(45)
Female
(44)
Aged
(36)
Middle Aged
(32)
Cardiology
(29)
Cardiovascular Disease
(28)
Diabetes
(27)
Treatment Outcome
(27)
Heart Failure
(26)
Mortality
(26)
Risk Factors
(25)
Diabetes Mellitus, Type 2 - Drug Therapy
(24)
Heart Attacks
(24)
Cardiovascular
(21)
Diabetes Mellitus
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial

Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials

Predicting In-Hospital Mortality in Patients Undergoing Percutaneous Coronary Intervention

Prevalence, Predictors, and In-Hospital Outcomes of Non-Infarct Artery Intervention During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction (from the National Cardiovascular Data Registry)

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c

Impact of Type 2 Myocardial Infarction (MI) on Hospital‐Level MI Outcomes: Implications for Quality and Public Reporting

Contemporary Trends and Outcomes of Percutaneous and Surgical Aortic Valve Replacement in Patients With Cancer

State Mandated Public Reporting and Outcomes of Percutaneous Coronary Intervention in the United States

Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors

Multivessel vs culprit-only percutaneous coronary intervention among patients 65 years or older with acute myocardial infarction

Meta‐analysis of transfemoral TAVR versus surgical aortic valve replacement

Differences in Inpatient Outcomes After Surgical Aortic Valve Replacement at Transcatheter Aortic Valve Replacement (TAVR) and Non-TAVR Centers

Response to Letter Regarding Article, “Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial”

Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors)

In-Hospital Outcomes After Transcatheter Versus Surgical Aortic Valve Replacement in Octogenarians

Patient and Hospital Characteristics Associated With Inappropriate Percutaneous Coronary Interventions

Collaborative quality improvement vs public reporting for percutaneous coronary intervention: A comparison of percutaneous coronary intervention in New York vs Michigan

Do Dipeptidyl Peptidase-4 Inhibitors Increase the Risk of Heart Failure?

Another Step Forward in Our Ability to Predict Percutaneous Coronary Intervention Outcomes

Are All Clinical Trial Sites Created Equal?

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death: Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry

Temporal Trends and Predictors in the Use of Aldosterone Antagonists Post-Acute Myocardial Infarction

Blood pressure lowering in the prevention of type 2 diabetes

Suchergebnisse filtern